Cargando…
Metformin and Malignant Tumors: Not Over the Hill [Response to Letter]
Autores principales: | Leng, Weiling, Jiang, Juan, Chen, Bing, Wu, Qinan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435614/ https://www.ncbi.nlm.nih.gov/pubmed/34526792 http://dx.doi.org/10.2147/DMSO.S336807 |
Ejemplares similares
-
Metformin and Malignant Tumors: Not Over the Hill
por: Leng, Weiling, et al.
Publicado: (2021) -
Metformin and Malignant Tumors: Not Over the Hill: A Short Comment [Letter]
por: Rastmanesh, Reza
Publicado: (2021) -
Depths of Malignancy: On the Prognosis of Breast Cancer [Response to Letter]
por: He, Jing, et al.
Publicado: (2023) -
Response to Comment to the Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Response To Letter]
por: Dzięgielewska-Gęsiak, Sylwia, et al.
Publicado: (2022) -
Reply to Letter to the Editor Regarding Article: “Considering the Potential Benefits of Over-The-Counter Naloxone” [Response To Letter]
por: Evoy, Kirk E, et al.
Publicado: (2021)